Two medical device manufacturers — one of which was previously headquartered in San Diego — will pay nearly $39 million to resolve allegations that they knowingly sold defective blood coagulation monitors and billed Medicare for them.
Two medical device manufacturers — one of which was previously headquartered in San Diego — will pay nearly $39 million to resolve allegations that they knowingly sold defective blood coagulation monitors and billed Medicare for them.
This website, like most media sites, uses small files called cookies to anonymously customize the advertising that you see. Learn more about how we use cookies in our cookie policy.
